Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
13.02.26
/
50%
€420.00
Target price
13.02.27
-
Performance (%)
4.02%
Price
14.08.26
€436.90
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 4.02%. This prediction currently runs until 13.02.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.794% | 1.794% |
| iShares Core DAX® | 0.437% | 5.640% |
| iShares Nasdaq 100 | 1.057% | 0.282% |
| iShares Nikkei 225® | 1.769% | 0.406% |
| iShares S&P 500 | 0.368% | 1.920% |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.25
05.05.26
05.05.26
€527.05
05.05.27
05.05.27
22.30%
14.08.26
14.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.55
10.04.26
10.04.26
€523.50
10.04.27
10.04.27
17.59%
14.08.26
14.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€429.85
10.03.26
10.03.26
€512.68
10.03.27
10.03.27
1.64%
14.08.26
14.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€375.90
03.12.25
03.12.25
€443.40
03.12.26
03.12.26
16.23%
14.08.26
14.08.26